Published in J Immunol on April 01, 1985
Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med (1992) 1.65
CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol (2012) 1.57
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest (1987) 1.46
Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc Natl Acad Sci U S A (1998) 1.36
Involvement of Lyt-2 and L3T4 in activation of hapten-specific Lyt-2+ L3T4+ T-cell clones. Proc Natl Acad Sci U S A (1986) 1.35
Functional and phenotypic analysis of porcine peripheral blood CD4/CD8 double-positive T cells. Immunology (1996) 1.29
Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology (2001) 1.18
Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men. Clin Exp Immunol (1988) 1.16
CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection. Proc Natl Acad Sci U S A (2004) 1.16
HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elements. J Virol (2011) 1.10
TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. Am J Pathol (2003) 1.05
The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond B Biol Sci (2001) 1.04
Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells. Immunology (1986) 1.01
Ber-ACT8: new monoclonal antibody to the mucosa lymphocyte antigen. J Clin Pathol (1991) 0.98
Simian immunodeficiency virus infection of CD8+ lymphocytes in vivo. J Virol (1996) 0.97
Expression of CD8alpha identifies a distinct subset of effector memory CD4+ T lymphocytes. Immunology (2006) 0.96
Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C. PLoS One (2011) 0.95
Beta-catenin signaling mediates CD4 expression on mature CD8+ T cells. J Immunol (2010) 0.93
Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface. Blood (2009) 0.93
Class II major histocompatibility complex molecules regulate the development of the T4+T8- inducer phenotype of cultured human thymocytes. Proc Natl Acad Sci U S A (1985) 0.92
Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression. Immunology (1987) 0.89
Distribution of T-lymphocyte subsets in porcine lymphoid tissues. Immunology (1987) 0.89
Age-related increase of peripheral CD4+ CD8+ double-positive T lymphocytes in cynomolgus monkeys: longitudinal study in relation to thymic involution. Immunology (2003) 0.88
Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation. J Virol (1998) 0.87
Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients. PLoS Negl Trop Dis (2011) 0.85
Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology (1991) 0.85
Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura. Clin Exp Immunol (1987) 0.85
Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques. Virology (2008) 0.84
Clonal analysis of CD4+/CD8+ T cells in a patient with aplastic anemia. J Clin Invest (1991) 0.82
Characterization of circulating CD4+ CD8+ lymphocytes in healthy individuals prompted by identification of a blood donor with a markedly elevated level of CD4+ CD8+ lymphocytes. Clin Diagn Lab Immunol (1994) 0.82
Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease. Clin Exp Immunol (1998) 0.81
Glucocorticoids induce the expression of CD8 alpha chains on concanavalin A-activated rat CD4+ T cells: induction is inhibited by rat recombinant interleukin 4. J Exp Med (1992) 0.81
Decreases in alpha beta T cell receptor negative T cells and CD8 cells, and an increase in CD4+ CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clin Exp Immunol (1992) 0.81
Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection. Am J Respir Cell Mol Biol (2016) 0.81
Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat. Immunology (2000) 0.80
Migration of CD8+ T Cells into the Central Nervous System Gives Rise to Highly Potent Anti-HIV CD4dimCD8bright T Cells in a Wnt Signaling-Dependent Manner. J Immunol (2015) 0.79
Increased interleukin-2 receptor expression after mitogen stimulation on CD4- and CD8-positive lymphocytes and decreased interleukin-2 production in HTLV-III antibody-positive symptomatic individuals. Immunology (1986) 0.79
Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4. Br J Cancer (1996) 0.78
Recirculation of lymphocyte subsets (CD5+, CD4+, CD8+, SBU-T19+ and B cells) through gut and peripheral lymph nodes. Immunology (1989) 0.77
Defective T-cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfunction after controlled murine injury. Ann Surg (1989) 0.76
An eight-colour flow cytometric method for the detection of reference values of lymphocyte subsets in selected healthy donors. Clin Exp Med (2013) 0.76
Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions. Clin Exp Immunol (2014) 0.76
Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media. Front Vet Sci (2016) 0.75
Development and characterisation of T lymphocyte lines from human small intestinal biopsies. Gut (1989) 0.75
Phenotype and polarization of autologous T cells by biomaterial-treated dendritic cells. J Biomed Mater Res A (2014) 0.75
CD40L confers helper functions to human intra-melanoma class-I-restricted CD4(+)CD8(+) double positive T cells. Oncoimmunology (2016) 0.75
The differentiation and function of human T lymphocytes. Cell (1980) 11.88
Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A (1980) 11.23
Monoclonal antibodies defining distinctive human T cell surface antigens. Science (1979) 10.50
Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 10.28
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med (1983) 9.23
An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell (1984) 7.56
A monoclonal antibody reactive with human peripheral blood monocytes. J Immunol (1980) 6.96
The isolation and characterization of the human suppressor inducer T cell subset. J Immunol (1985) 6.69
Specific purification of lymphocyte populations on a digestible immunoabsorbent. J Immunol (1973) 6.64
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol (1979) 6.08
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol (1980) 6.05
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A (1982) 5.85
Characterization of a human B lymphocyte-specific antigen. J Immunol (1980) 5.76
The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. Proc Natl Acad Sci U S A (1988) 5.75
A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell (1991) 5.65
Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol (1979) 5.63
Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol (1974) 5.50
The isolation and characterization of the human helper inducer T cell subset. J Immunol (1985) 5.21
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression. J Exp Med (1979) 5.19
Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor. Nature (1983) 4.96
Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell (1982) 4.86
Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med (1980) 4.80
Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A (1984) 4.78
Antigens on human monocytes identified by monoclonal antibodies. J Immunol (1981) 4.67
Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens. J Exp Med (1978) 4.51
Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. J Immunol (1978) 4.33
Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med (1983) 4.10
Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci U S A (1976) 4.05
A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature (1980) 3.90
Distribution of T cell subsets in human lymph nodes. J Exp Med (1981) 3.64
The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol (1980) 3.49
Location of T cell and major histocompatibility complex antigens in the human thymus. J Exp Med (1980) 3.41
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
A monoclonal antibody blocking human T cell function. Eur J Immunol (1980) 3.33
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med (1987) 3.14
Aberrations of suppressor T cells in human graft-versus-host disease. N Engl J Med (1979) 3.10
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors. Cell (1983) 3.07
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J Exp Med (1980) 3.03
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A (2003) 2.95
Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures. Proc Natl Acad Sci U S A (1983) 2.93
Structural analysis of differentiation antigens Mo1 and Mo2 on human monocytes. Hybridoma (1982) 2.92
Characterization of a human B cell-specific antigen (B2) distinct from B1. J Immunol (1981) 2.86
The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A (1989) 2.80
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med (1990) 2.79
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest (1985) 2.77
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74
A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med (1988) 2.74
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med (1989) 2.69
Con A-inducible suppression of MLC: evidence for mediation by the TH2 + T cell subset in man. J Immunol (1979) 2.63
Reversible cerebral segmental vasoconstriction. Stroke (1988) 2.63
Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol (1982) 2.60
Surface structures involved in target recognition by human cytotoxic T lymphocytes. Science (1982) 2.52
Stages of B cell differentiation in human lymphoid tissue. J Exp Med (1981) 2.49
Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med (1979) 2.48
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science (1998) 2.46
Characterization of an antigen expressed by human natural killer cells. J Immunol (1983) 2.44
Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science (1993) 2.40
Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes. Nature (1981) 2.39
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J Immunol (1985) 2.37
Immunogenicity of a series of alpha,N-DNP-L-lysines. Biochemistry (1965) 2.35
Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest (1981) 2.34
Detection, isolation, and functional characterization of two human T-cell subclasses bearing unique differentiation antigens. J Exp Med (1977) 2.34
Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci U S A (1978) 2.32
Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol (1978) 2.30
In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med (1985) 2.27
A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol (1990) 2.24
The human T-cell receptor. Annu Rev Immunol (1984) 2.23
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med (1980) 2.21
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science (1983) 2.21
The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med (1971) 2.18
Acquired immunodeficiency syndrome in a colony of macaque monkeys. Proc Natl Acad Sci U S A (1983) 2.17
Calcium dependency of antigen-specific (T3-Ti) and alternative (T11) pathways of human T-cell activation. Proc Natl Acad Sci U S A (1984) 2.17
Beyond water activity: recent advances based on an alternative approach to the assessment of food quality and safety. Crit Rev Food Sci Nutr (1991) 2.15
Immunologic functions of isolated human lymphocyte subpopulations. II. Antigen triggering of T and B cells in vitro. J Immunol (1974) 2.10
The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens. J Exp Med (1987) 2.08
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Phenotypic and functional distinctions between the TH2+ and JRA+ T cell subsets in man. J Immunol (1979) 2.06
1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol (1989) 2.04
Immunochemical studies on the antigenic determinants required to elicit delayed and immediate hypersensitivity reactions. J Exp Med (1966) 2.03
Delineation of a human T cell subset responsible for lepromin-induced suppression in leprosy patients. J Immunol (1980) 2.02
Phase-field model of mode III dynamic fracture. Phys Rev Lett (2001) 1.99
T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. J Immunol (1980) 1.98
VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med (1990) 1.95
Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man. Hum Immunol (1981) 1.94
Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature (1983) 1.93
Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc Natl Acad Sci U S A (1988) 1.93
A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest (1981) 1.93
Expression of cell surface markers after human B lymphocyte activation. Proc Natl Acad Sci U S A (1981) 1.91
Immunochemical studies on the specificity of cellular hypersensitivity. The in vitro inhibition of peritoneal exudate cell migration by cehmically defined antigens. J Exp Med (1968) 1.90
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med (1985) 1.87